Biontech Se Stock Technical Analysis

BNTX Stock  USD 86.40  0.06  0.07%   
As of the 17th of April 2024, BioNTech shows the Mean Deviation of 1.29, risk adjusted performance of (0.09), and Standard Deviation of 1.65. BioNTech SE technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for BioNTech SE, which can be compared to its peers. Please confirm BioNTech SE variance and skewness to decide if BioNTech SE is priced correctly, providing market reflects its regular price of 86.4 per share. Given that BioNTech has information ratio of (0.19), we suggest you to validate BioNTech SE's prevailing market performance to make sure the company can sustain itself at a future point.

BioNTech Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioNTech, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioNTech
  
BioNTech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

BioNTech Analyst Consensus

Target PriceAdvice# of Analysts
151.1Buy19Odds
BioNTech SE current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most BioNTech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioNTech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioNTech SE, talking to its executives and customers, or listening to BioNTech conference calls.
BioNTech Analyst Advice Details
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BioNTech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BioNTech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

BioNTech SE Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioNTech SE volatility. High ATR values indicate high volatility, and low values indicate low volatility.

BioNTech SE Trend Analysis

Use this graph to draw trend lines for BioNTech SE. You can use it to identify possible trend reversals for BioNTech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioNTech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

BioNTech Best Fit Change Line

The following chart estimates an ordinary least squares regression model for BioNTech SE applied against its price change over selected period. The best fit line has a slop of   0.12  , which may suggest that BioNTech SE market price will keep on failing further. It has 122 observation points and a regression sum of squares at 578.84, which is the sum of squared deviations for the predicted BioNTech price change compared to its average price change.

About BioNTech Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioNTech SE on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioNTech SE based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioNTech SE price pattern first instead of the macroeconomic environment surrounding BioNTech SE. By analyzing BioNTech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioNTech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioNTech specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.01270.0113
Price To Sales Ratio6.025.71

BioNTech April 17, 2024 Technical Indicators

Most technical analysis of BioNTech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioNTech from various momentum indicators to cycle indicators. When you analyze BioNTech charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

BioNTech April 17, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioNTech stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for BioNTech Stock analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is BioNTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Earnings Share
4.08
Revenue Per Share
15.873
Quarterly Revenue Growth
(0.65)
Return On Assets
0.0262
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.